Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Phase 1c > Diabetes and Pituitary > Flashcards

Diabetes and Pituitary Flashcards

1
Q

How does Diabetes Mellitus type 1 cause hyperglycaemia

A

pancreatic islet beta cells destroyed (autoimmune response)
ABSOLUTE insulin insufficiency leading to lipolysis and ketogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how does diabetes mellitus type 2 cause hyperglycaemia

A

reduced peripheral sensitivity to insulin
reduced insulin production (over time)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

which alleles are associated with type 1 diabetes

A

HLA DR3/4 (hoes in la diabetic aRound 3/4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

risk factors for t2d

A

obesity, HTN, inactivity, disturbed lipids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

typical patient profile T1DM

A

<20 yrs
FH autoimmune
presents with polyuria and polydipsia
presents with weight loss and fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DKA symptoms and signs

A

nausea and vomiting
abdo pain
kussmaul breathing (deep hyperventilation)
sweet-smelling breath (ketonaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

typical patient profile T2DM

A

> 40 yrs
often asymptomatic
polyuria, polydipsia
RF: obesity, hypertension, south asian/ afro-carribean
examination: acathosis nigricans, symptoms of micro/macrovascular complications of T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is a diagnosis of DM made

A

symptomatic + 1 test
asymptomatic + 2 different tests on two different days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

tests specific for T1DM

A

urine dip for glucose and ketones
specific antibodies are useful to distinguish between T1 and T2 but not necessary for T1 diagnosis
Anti-GAD (80%) and islet cell antibodies (ICA) (70-80%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

tests for type 1 and 2

A

n= normal, d= diabetes, prediabetes is between

random glucose (n <11.1, d=>11.1)
fasting glucose (n <5.5, d=> 7.0)
2hr post prandial glucose (n< 7.8, d =>11.1)
HbA1c (n <42 [6%], d=> 48 [6.5%]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HbA1c should not be used in

A

children or young ppl
pt suspected of having T1DM
pt with symptoms of diabetes <2 months
pt at high risk and acutely ill
pt taking meds that cause rapid glucose rise (steroids, antipsychotics)
pt with acute pancreatic damage including pancreatic surgery
presence of factors that influence HbA1c

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Management of T1DM

A

insulin
personalised to pt
monitored daily using capillary glucose and over time using HbA1c (3mo)
basal-bolus regime = long acting (subcut insulin glargine o.d) + short acting (subcut insulin lispro and aspart pre-meal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T2D management summary

A

lifestyle mods
glycaemic control
lipid management
bp management
antiplatelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

lifestyle mods T2DM management

A

diet
exercise
education

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

glycaemic control T2DM management

A

If HbA1c > 48 on lifestyle modification start metformin
if HbA1c >58 metformin + another drug (DPP-4i, pioglitazone, sulfonylurea and sglt-2i)
if HbA1c still >58:
metformin + sulfonylurea + (DPP-4i or pioglitazone)
metformin + sglt-2i + (pioglitazone or sulfonylurea)
insulin based treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

BP management T2DM

A

all BP management starts with ACEi/ARB rather than CCB even if patient is black or over age 55

step 1: ACEi or ARB (ARB preferred for black pts)
step 2: add CCB or thiazide
step 3: ACEi/ARB + CCB + thiazide
check potassium, consult specialist
step 4: if K<4.5, add spironolactone. of K>4.5, add b-blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

lipid management T2DM

A

atorvastatin 20 mg o.d if 10-year cardiovascular event risk =>10%
atorvastatin 80 mg o.d if IHD/CVD/PAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

antiplatelet management (T2DM)

A

Aspirin 75mg for patients with IHD/CVD/CVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

A 65yr old man present to his GP for bp check. ambulatory bp constantly above 140/90. PMH shows gout and T2DM for which he takes metformin and allopurinol. He is black

which is the most appropriate drug

A: Amlodipine
B: Bendroflumethiazide
C: Irbesartan
D: Ramipril
E: Spironolactone

A

The correct answer is irbesartan. This medication is an angiotensin II receptor blocker (A2RB).
It is used to manage hypertension in diabetic patients, as it has a renoprotective effect.Black African and Afro-Caribbean patients are prescribed calcium channel blockers first-line for hypertension.
However, as the patient is diabetic, ACE inhibitors/A2RBs are preferred due to their renoprotective effect. In black African and Afro-Caribbean patients, A2RBs are preferred over ACE inhibitors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Complications for DM

A

Acute metabolic:
hypoglycaemia
DKA
hyperosmolar hyperglycaemic state

Long term microvascular:
retinopathy
neuropathy
nephropathy

long term macrovascular:
ischaemic heart disease
cerebrovascular disease
peripheral artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

plasma glucose hypoglycaemia

A

<3.6 mmol/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

cause of hypoglycaemia

A

inappropriate insulin regime
missed meals
drugs (sulfonylureas, SGLT-2 inhibitors etc)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

signs of hypoglycaemia

A

tachycardia
tremor
sweating
pallor
anxiety
drowsiness
confusion
altered behaviour (aggression)
coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Treatment of hypoglycaemia

A

give sugar
conscious - oral glucose and complex carb
impaired consciousness - IM glucagon 1mg
IV 10% dextrose infusion if glucagon fails to improve symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
A 20yr old man with T1DM brought into A+E following a seizure after a heavy night out yday. Injected insulin this morning but fell back asleep before eating. Drowsy in ambulance but now cannot be roused. Ambulance staff performed cap glucose which was 1.8 mmol what is most urgent step in the management of this pt A: IV insulin B: IM glucagon C: IL 0.9% saline D: feed sugary foods E: 500 mL 50% IV dextrose
This patient is experiencing severe hypoglycaemia with neuroglycopaenic effects of seizures and reduced consciousness B: administration of IM glucagon 1mg is the initial management for hypoglycaemic patients with reduced consciousness. It will stimulate the liver to convert glycogen to glucose and release this into the blood therefore increase hepatic glucose output and increasing blood sugar levels. If this does not bring glucose >4mmol/L after 10 mins, IV dextrose at 10% or 20% should be administered
26
Is DKA more common T1 or T2
T1
27
DKA triad
hyperglycaemia, ketonaemia and metabolic acidosis high levels of glucose cause polyuria which causes dehydration (treat with IV fluids) high levels of ketones (treat with insulin) is highly acidic which leads to enzyme dysfunction resulting in coma and death
28
DKA treatment
rehydrate with IV fluids and reduce ketones with insulin
29
hyperosmolar hyperglycaemic state is more common in which type of diabetes
t2dm
30
difference in pathophysiology is DKA and HHS
DKA- absolute lack of insulin and increased stress hormones causing hyperglycaemia, ketonaemia and metabolic acidosis HHS- hyperglycaemia but no ketonaemia as still some insulin to suppress ketogenesis
31
difference in causes dka and hhs
both- infection, other acute illness and non-adherence to diabetes meds
32
signs and symptoms DKA and HHS
dka- collapse/confusion, abdo pain, nausea, vomiting, kussmaul breathing, dehydration hhs- same minus abdo pain
33
Ix results for DKA and HHS
dka: ketones > 3mmol/L, pH < 7.3, plasma glucose > 11 hhs: ketones <3mmol/L, pH normal, plasma glucose > 30
34
Mx for dka and hhs
fluids started first (normal saline) + potassium chloride (is k+ < 5.5) IV insulin after fluids and only when K+ not <3.5 include dextrose if fluids falls < 14 treat underlying cause
35
13 yr old boy presents to a+e with generalised abdo pain. nauseous and vomited 4 times. progressively getting drowsier. groans when you palpate his abdomen what is the most appropriate initial management option? A. fixed rate insulin infusion B. variable-rate insulin infusion C. 10 U actrapid STAT D. 10 ml 10% calcium gluconate E. IL IV 5% dextrose
A. DKA treatment is IV fluids, fixed-rate insulin infusion
36
background retinopathy: findings and management
blot and dot haemorrhages/ hard exudates mx: improve glycaemic control
37
pre-proliferative retinopathy: findings and management
background retinopathy findings + cotton wool spots mx: pan-retinal laser photocoagulation
38
proliferative retinopathy: signs and management
non-proliferative + new vessels on disk (neovascularisation) neovascularisation is often associated with retinal detachment and vitreous haemorrhage which leads to vision loss mx: pan-retinal laser photocoagulation
39
maculopathy retinopathy: signs and management
hard exudates happens to be near macula mx: intravitreal VEGF (vascular endothelial growth factor) inhibitors
40
nephropathy signs, ix and mx
signs: oedema, polyuria, lethargy, hypertension ix: 1st line urinalysis. increased ACR = microalbuminuria gold standard - renal biopsy showing Kimmelstiel Wilson nodules mx- ACEi/ARB (renoprotective) - improve glycaemic control
41
what do you find in peripheral neuropathy
glove and stocking distribution loss of sensation esp feet monofilament on lower limb exam loss of ankle jerk/vibration sense/fractures (Charcot's joint)
42
what do you find in mononeuropathy
sudden motor loss usually eg wrist drop, foot drop, 3rd nerve palsy
43
what do you find with autonomic neuropathy
difficulty swallowing, delayed gastric emptying, bladder dysfunction postural hypotension cardiac autonomic supply
44
mx of neuropathy
glycaemic control if painful use neuropathic pain agent (duloxetine, pregabalin, gabapentin)
45
what is diabetes insipidus
inadequate secretion or sensitivity to vasopressin (ADH) hypotonic polyuria
46
2 types of diabetes insipidus
cranial - lack of vasopressin release from posterior pituitary nephrogenic - collecting ducts insensitive to vasopressin
47
causes of cranial and nephrogenic DI
cranial: pituitary tumour/surgery, traumatic brain injury, infection (meningitis), sarcoidosis/TB, subarachnoid haemorrhage nephrogenic: lithium therapy, electrolyte imbalance (high Ca, low K), idiopathic, ureteric obstruction, inherited (AVPV2 gene)
48
control of osmolality following water deprivation
water deprivation increased serum osmolality osmoreceptors stimulated posterior pituitary releases vasopressin (ADH) increased water reabsorption from renal collecting ducts reduced urine volume, increased urine osmolality and reduced serum osmolality
49
presentation for DI
polyuria (incl nocturia) polydipsia dehydration: tachycardia/reduced tissue turgor, dry mucous membranes signs of the cause (eg bitemporal hemianopia)
50
Ix for DI
U+Es (Ca/K for cause, Na (rarely raised), increased urea) glucose to exclude DM plasma osmolality = high urine osmolality = low (>700 excludes DI)
51
diagnostic test for types of DI
water deprivation test water restricted fr 8 hrs plasma and urine osmolality measured every hour after 8 hrs give desmopressin and measure urine osmolality
52
management of DI
treat the cause cranial: intranasal desmopressin (should not drink large amounts of water on this med) nephrogenic: thiazide diuretic, low salt/protein diet
53
SIADH Ix
serum Na low urine Osm high urine Na high
54
causes of SIADH
CNS: Subarachnoid haemorrhage, tumour, TB pulmonary: pneumonia, bronchiectasis malignancy: small cell lung cancer drugs: carbamazepine, SSRI idiopathic
55
management for mild SIADH
treat cause immediate fluid restrict for hyponatraemia if ineffective: oral demeclocycline, IV vaptan
56
normal serum sodium
135-145 mEg/L
57
hypovolaemic hyponatraemia causes and management
causes: diarrhoea, vomiting, diuretics management: IV fluids
58
euvolaemic hyponatraemia causes and management
causes: SIADH, hypothyroidism, adrenal insufficiency 1.TFTS - if normal then 2) do a shorty synacthen test to look for adrenal insufficiency 3) if normal look for cause, eg drug history, breast exam, CXR to look for lung pathology, brain scan
59
hypervolaemic hyponatraemia causes and Mx
causes: liver failure, renal failure, heart failure Mx: fluid restrict
60
what to do in case of urinary sodium <20
if very severe hyponatraemia (seizures, reduced consciousness), give slow hypertonic saline (too fast can cause central pontine myelinolysis)
61
sodium levels for hypernatraemia
serum Na > 145 mEg/L
62
causes of hypernatraemia
unreplaced water loss - GI losses, sweat loss - renal losses: osmotic diuresis (eg HHS), diabetes insipidus sodium overload (rare) - Cushing's, primary aldosteronism, iatrogenic (hypertonic saline)
63
hypernatraemia presentation
lethargy irritability thirst signs of dehydration confusion coma fits
64
management of hypernatraemia
correct water deficit - 5% dextrose correct ECF volume depletion - 0.9% saline measure Na+ every 4-6hrs
65
types of pituitary adenoma
non-functional -do not release hormones -test visual fields - brain MRI with contrast functional - acromegaly (GH secreting) - prolactinoma (prolactin secreting) - Cushing's disease (ACTH secreting) pituitary adenomas of either type can compress other parts of the pituitary gland (hypopituitarism) can compress optic chiasm causing bitemporal hemianopia
66
what are the causes of hyperprolactinaemia
physiology: -pregnancy -breast feeding pathological: -prolactinoma -other pituitary adenoma (stalk compression) -primary hypothyroidism
67
presentation of men with hyperprolactinaemia
loss of libido, erectile dysfunction, infertility, galactorrhoea (uncommon) mass effect of tumour: headaches/visual field defect
68
presentation of women with hyperprolactinaemia
galactorrhoea, secondary amenorrhoea/oligomenorrhoea, loss of libido, infertility mass effect of tumour: headaches/visual field defect
69
how does hyperprolactinaemia affect GnRH
high prolactin suppresses GnRH pulsatility
70
Ix for hyperprolactinaemia
pregnancy tests (exclude physiological hyperprolactinaemia) TFTs Basal serum prolactin MRI preferred imaging
71
Prolactinoma management
1st line- Dopamine receptor (D2) agonists eg bromocriptine, cabergoline > reduce prolactin secretion and tumour size 2nd line- Surgery
72
when to suspects T2DM in adult
if they present with persistent hyperglycaemia plus clinical features eg polydipsia, polyuria, blurred vision, unexplained weight loss, recurrent infections, tiredness, acanthosis nigricans
73
what is persistent hyperglycaemia defined as
HbA1c of 48 mmol/mol (6.5%) or more fasting glucose of 7.0+ random plasma glucose pf 11.1mmol/L or more in presence of clinical features
74
how is t2dm diagnosed
symptomatic: one abnormal HbA1c or plasma glucose result asymptomatic: repeat testing
75
metformin use has increased risk of which vitamin deficiency
b12
76
which drug class to offer diabetic patients with cvs disease
SGLT-2 inhibitor
77
what class of drug are gliclazide, glimepiride, glipizide and tolbutamide
sulfonylureas associated with hypoglycaemia, weight gain
78
what class of drugs are alogliptin, linagliptin, sitagliptin, saxagliptin and vildagliptin
DPP-4 inhibitors
79
what class of drugs are canagliflozin, dapagliflozin, empagkiflozin and ertygliflozin
SGLT2 inhibitor promote weight loss, improve cardiovascular outcomes
80
what class of drugs are dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide
GLP-1 should be reserved for combination therapy when other options failed

Phase 1c (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions